Effect of Steatohepatitis Associated with Irinotecan or Oxaliplatin Pretreatment on Resectability of Hepatic Colorectal Metastases

Mathijssen, 2001, Clinical pharmacokinetics and metabolism of irinotecan (CPT-11), Clin Cancer Res, 7, 2182

Carrato, 2002, Oxaliplatin, Crit Rev Oncol Hematol, 44, 29, 10.1016/S1040-8428(01)00192-5

1998, Efficacy of intravenous continuous infusion of fluourouracil compared with bolus administration in advanced colorectal cancer, J Clin Oncol, 16, 301, 10.1200/JCO.1998.16.1.301

Saltz, 2000, Irinotecan plus fluorouracil and leukovorin for metastatic colorectal cancer, N Engl J Med, 343, 905, 10.1056/NEJM200009283431302

Douilliard, 2000, Irinotecan combined with fluorouracil alone as first-line treatment for metastatic colorectal cancer, Lancet, 355, 1041, 10.1016/S0140-6736(00)02034-1

Kohne, 2003, Irinotecan improves the activity of the AIO regimen in metastatic colorectal cancer, Proc Am Soc Clin Oncol, 22

de Gramont, 2000, Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer, J Clin Oncol, 18, 2938, 10.1200/JCO.2000.18.16.2938

Giacchetti, 2000, Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first line treatment of metastatic colorectal cancer, J Clin Oncol, 18, 136, 10.1200/JCO.2000.18.1.136

Goldberg, 2004, A randomized controlled trial of fluorouracil plus leucovorin, irinotecan and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer, J Clin Oncol, 22, 23, 10.1200/JCO.2004.09.046

Souglakos, 2002, Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer, J Clin Oncol, 20, 2651, 10.1200/JCO.2002.08.015

Schmoll, 2002, The role of oxaliplatin in the treatment of advanced metastatic colorectal cancer, Semin Oncol, 29, 34, 10.1053/sonc.2002.35531

Bismuth, 1996, Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy, Ann Surg, 224, 509, 10.1097/00000658-199610000-00009

Allen, 2003, Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases, J Gastrointest Surg, 7, 109, 10.1016/S1091-255X(02)00121-X

Rubbia-Brandt, 2004, Severe hepatic sinusoidal obstruction associated with oxaliplatin-induced chemotherapy in patients with metastatic colorectal cancer, Ann Oncol, 15, 460, 10.1093/annonc/mdh095

Parikh, 2003, Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy, J Gastrointest Surg, 7, 1082, 10.1016/j.gassur.2003.08.005

Kooby, 2003, Impact of steatosis on perioperative outcome following hepatic resection, J Gastrointest Surg, 7, 1034, 10.1016/j.gassur.2003.09.012

Behrns, 1998, Hepatic steatosis as a potential risk factor for major hepatic resection, J Gastrointest Surg, 2, 292, 10.1016/S1091-255X(98)80025-5

Brunt, 1999, Nonalcoholic steatohepatitis, Am J Gastroenterol, 94, 2467, 10.1111/j.1572-0241.1999.01377.x

James, 2003, Nonalcoholic fatty liver disease, Vol. 2, 2437

Bellantani, 2000, Prevalence of and risk factors for hepatic steatosis in Northern Italy, Ann Intern Med, 132, 112, 10.7326/0003-4819-132-2-200001180-00004

Day, 1998, Hepatic steatosis—innocent bystander or guilty party?, Hepatology, 27, 1463, 10.1002/hep.510270601

Fan, 1998, Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism, J Biol Chem, 273, 15639, 10.1074/jbc.273.25.15639

Wigg, 2001, The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxemia, and tumor necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis, Gut, 48, 206, 10.1136/gut.48.2.206

Hocking, 1998, Long term consequences after jejunoileal bypass for morbid obesity, Dig Dis Sci, 43, 2493, 10.1023/A:1026698602714

Craig, 1980, Severe hepatocellular reaction resembling alcoholic steatohepatitis with cirrhosis after massive small bowel resection and prolonged parenteral nutrition, Gastroenterology, 79, 131, 10.1016/0016-5085(80)90087-6

Didolkar, 1989, Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure, Surg Gynecol Obstet, 169, 17

Elias, 1995, Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intraarterial hepatic chemotherapy for initially unresectable hepatic tumors, J Am Coll Surg, 180, 213

Rothenberg, 2001, Mortality associated with irinotecan plus bolus fluorouracil/leucovorin, J Clin Oncol, 19, 3801, 10.1200/JCO.2001.19.18.3801

Andre, 1999, Multicenter phase II study of bimonthly high-dose leucovorin fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen, J Clin Oncol, 17, 3560, 10.1200/JCO.1999.17.11.3560

Abdalla, 2004, Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases, Ann Surg, 239, 818, 10.1097/01.sla.0000128305.90650.71

Azoulay, 2000, Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization, Ann Surg, 231, 480, 10.1097/00000658-200004000-00005